Monogram Orthopaedics Inc
NASDAQ:MGRM
Net Margin
Monogram Orthopaedics Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
M
|
Monogram Orthopaedics Inc
NASDAQ:MGRM
|
100.3m USD | N/A | |
UK |
E
|
Eight Capital Partners PLC
F:ECS
|
633.6T EUR | N/A | |
US |
G
|
GE Vernova LLC
NYSE:GEV
|
132.9B USD |
5%
|
|
US |
C
|
China Industrial Group Inc
OTC:CIND
|
91.7B USD |
9%
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
81.5B Zac |
69%
|
|
US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
80B USD |
-44%
|
|
US |
C
|
Circle Internet Group Inc
NYSE:CRCL
|
53B USD | N/A | |
US |
![]() |
Coupang Inc
F:788
|
44.3B EUR |
1%
|
|
ID |
![]() |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
553T IDR |
18%
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
26.6B CHF |
5%
|
|
US |
R
|
Reddit Inc
NYSE:RDDT
|
25.6B USD |
8%
|
Monogram Orthopaedics Inc
Glance View
Monogram Orthopaedics Inc is a US-based company operating in industry. The company is headquartered in Brooklyn, New York. The company went IPO on 2023-05-18. Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture for mass personalization of orthopedic implants by linking three-dimensional (3D) printing and robotics via automated digital image analysis algorithms. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The company has a navigated robot prototype that can optically track a simulated surgical target and execute optimized auto-generated cut paths for precision insertion of implants in synthetic bone specimens. These implants and cut paths are generated with Monogram software algorithms. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography scan. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Monogram Orthopaedics Inc's most recent financial statements, the company has Net Margin of 0%.